- Home
- HOOK vs MSN Comparison
HOOK vs MSN Comparison
Compare HOOK & MSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- MSN
- Stock Information
- Founded
- HOOK 2011
- MSN 1948
- Country
- HOOK United States
- MSN United States
- Employees
- HOOK N/A
- MSN N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- MSN Consumer Electronics/Appliances
- Sector
- HOOK Health Care
- MSN Consumer Staples
- Exchange
- HOOK Nasdaq
- MSN Nasdaq
- Market Cap
- HOOK 9.3M
- MSN 8.6M
- IPO Year
- HOOK 2019
- MSN 1994
- Fundamental
- Price
- HOOK $1.59
- MSN $0.42
- Analyst Decision
- HOOK Buy
- MSN
- Analyst Count
- HOOK 4
- MSN 0
- Target Price
- HOOK $10.67
- MSN N/A
- AVG Volume (30 Days)
- HOOK 207.3K
- MSN 4.9K
- Earning Date
- HOOK 05-15-2025
- MSN 06-26-2025
- Dividend Yield
- HOOK N/A
- MSN N/A
- EPS Growth
- HOOK N/A
- MSN N/A
- EPS
- HOOK N/A
- MSN N/A
- Revenue
- HOOK $9,351,000.00
- MSN $11,140,000.00
- Revenue This Year
- HOOK N/A
- MSN N/A
- Revenue Next Year
- HOOK N/A
- MSN N/A
- P/E Ratio
- HOOK N/A
- MSN N/A
- Revenue Growth
- HOOK N/A
- MSN 27.46
- 52 Week Low
- HOOK $0.72
- MSN $0.35
- 52 Week High
- HOOK $9.09
- MSN $0.83
- Technical
- Relative Strength Index (RSI)
- HOOK 59.36
- MSN 53.44
- Support Level
- HOOK $1.45
- MSN $0.38
- Resistance Level
- HOOK $1.62
- MSN $0.43
- Average True Range (ATR)
- HOOK 0.16
- MSN 0.02
- MACD
- HOOK -0.00
- MSN 0.00
- Stochastic Oscillator
- HOOK 67.57
- MSN 75.00
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.
About MSN Emerson Radio Corporation
Emerson Radio Corp operates in the consumer electronics industry. The company designs, sources, imports, and markets a variety of houseware and consumer electronic products, and licenses the Emerson trademark domestically and internationally. Its products are offered to encompass televisions, digital versatile disc players and video cassette recorders, audio accessories, microwave ovens, home theatres, high-end audio products, office products, mobile stereo, and wireless products. geographically, it derives a majority of its revenue from the United States.